You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
多瑞醫藥(301075.SZ)擬斥1280萬元成立控股子公司瑞蒂蓮醫藥
格隆匯 02-07 12:47

格隆匯2月7日丨多瑞醫藥(301075.SZ)公佈,根據公司經營及戰略發展的需要,為充分利用、整合各方資源優勢,公司與河南正新源醫療科技有限公司(簡稱“河南正新源”)、自然人林曉娜共同出資設立武漢市瑞蒂蓮醫藥科技有限公司(簡稱“瑞蒂蓮醫藥”)。

瑞蒂蓮醫藥註冊資本為人民幣2000.00萬元。其中多瑞醫藥認繳出資額為1280萬元,佔合資公司64.00%的股權;河南正新源認繳出資額為520萬元,佔合資公司26.00%的股權;林曉娜認繳出資額為200萬元,佔合資公司10.00%的股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account